Interferon-β signaling contributes to ras transformation

PLoS ONE

Volumn 6, Issue 8, 2011, Pages

  Tsai, Yu Chen ^a   Pestka, Sidney ^a   Wang, Lu Hai ^b   Runnels, Loren W ^a   Wan, Shan ^a   Lyu, Yi Lisa ^a   Liu, Leroy F ^a  

^a RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON RECEPTOR; ALPHA TUBULIN; BETA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON; INTERFERON STIMULATED GENE FACTOR 5; K RAS PROTEIN; NUCLEIC ACID BINDING PROTEIN; PROTEIN TYROSINE KINASE; RAS PROTEIN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; UVOMORULIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BREAST CANCER; CANCER CELL; CANCER CELL CULTURE; CELL CULTURE; CELL MIGRATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVITY; EXPRESSION VECTOR; MALIGNANT TRANSFORMATION; MAMMAL CELL; NONHUMAN; ONCOGENE H RAS; ONCOGENE K RAS; ONCOGENE RAS; ONCOGENE SRC; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; UPREGULATION;

EID: 80052301269     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0024291     Document Type: Article

References (35)

1. Wenzel J, Tomiuk S, Zahn S, Küsters D, Vahsen A, et al. (2008) Transcriptional profiling identifies an interferon-associated host immune response in invasive squamous cell carcinoma of the skin. International Journal of Cancer 123: 2605-2615.
2. Chi L-M, Lee C-W, Chang K-P, Hao S-P, Lee H-M, et al. (2009) Enhanced Interferon Signaling Pathway in Oral Cancer Revealed by Quantitative Proteome Analysis of Microdissected Specimens Using 16O/18O Labeling and Integrated Two-dimensional LC-ESI-MALDI Tandem MS. Molecular & Cellular Proteomics 8: 1453-1474.
3. Andersen JB, Hassel BA, (2006) The interferon regulated ubiquitin-like protein, ISG15, in tumorigenesis: Friend or foe? Cytokine & Growth Factor Reviews 17: 411-421.
4. Desai SD, Haas AL, Wood LM, Tsai Y-C, Pestka S, et al. (2006) Elevated Expression of ISG15 in Tumor Cells Interferes with the Ubiquitin/26S Proteasome Pathway. Cancer Research 66: 921-928.
5. Andersen JB, Aaboe M, Borden EC, Goloubeva OG, Hassel BA, et al. (2006) Stage-associated overexpression of the ubiquitin-like protein, ISG15, in bladder cancer. Br J Cancer 94: 1465-1471.
6. Kiessling A, Hogrefe C, Erb S, Bobach C, Fuessel S, et al. (2009) Expression, regulation and function of the ISGylation system in prostate cancer. Oncogene 28: 2606-2620.
7. Ye H, Yu T, Temam S, Ziober BL, Wang J, et al. (2008) Transcriptomic dissection of tongue squamous cell carcinoma. BMC Genomics 9: 69.
8. Bektas N, Noetzel E, Veeck J, Press M, Kristiansen G, et al. (2008) The ubiquitin-like molecule interferon-stimulated gene 15 (ISG15) is a potential prognostic marker in human breast cancer. Breast Cancer Research 10: R58.
9. Karnoub AE, Weinberg RA, (2008) Ras oncogenes: split personalities. Nat Rev Mol Cell Biol 9: 517-531.
10. Thiery JP, (2002) Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2: 442-454.
11. Campbell PM, Der CJ, (2004) Oncogenic Ras and its role in tumor cell invasion and metastasis. Seminars in Cancer Biology 14: 105-114.
12. Cano A, Perez-Moreno MA, Rodrigo I, Locascio A, Blanco MJ, et al. (2000) The transcription factor Snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression. Nat Cell Biol 2: 76-83.
13. Hajra KM, Ji X, Fearon ER, (1999) Extinction of E-cadherin expression in breast cancer via a dominant repression pathway acting on proximal promoter elements. Oncogene 18: 7274-7279.
14. Dorudi S, Hanby AM, Poulsom R, Northover J, Hart IR, (1995) Level of expression of E-cadherin mRNA in colorectal cancer correlates with clinical outcome. Br J Cancer 71: 614-616.
15. Kowalski P, Rubin M, Kleer C, (2003) E-cadherin expression in primary carcinomas of the breast and its distant metastases. Breast Cancer Res 5: 217-222.
16. Nguyen KT, Wang WJ, Chan JL, Wang LH, (2000) Differential requirements of the MAP kinase and PI3 kinase signaling pathways in Src- versus insulin and IGF-1 receptors-induced growth and transformation of rat intestinal epithelial cells. Oncogene 19: 5385-5397.
17. Dawson PJ, Wolman SR, Tait L, Heppner GH, Miller FR, (1996) MCF1 OAT: A Model for the Evolution of Cancer from Proliferative Breast Disease. Am J Pathol 148: 313-319.
18. Lenardo MJ, Fan C-M, Maniatis T, Baltimore D, (1989) The involvement of NF-[kappa]B in [beta]-interferon gene regulation reveals its role as widely inducible mediator of signal transduction. Cell 57: 287-294.
19. Vinas-Castells R, Beltran M, Valls G, Gomez I, Garcia JM, et al. (2010) The Hypoxia-controlled FBXL14 Ubiquitin Ligase Targets SNAIL1 for Proteasome Degradation. Journal of Biological Chemistry 285: 3794-3805.
20. Nielsch U, Pine R, Zimmer SG, Babiss LE, (1992) Induced expression of the endogenous beta interferon gene in adenovirus type 5-transformed rat fibroblasts. J Virol 66: 1884-1890.
21. Sarkar SN, Peters KL, Elco CP, Sakamoto S, Pal S, et al. (2004) Novel roles of TLR3 tyrosine phosphorylation and PI3 kinase in double-stranded RNA signaling. Nat Struct Mol Biol 11: 1060-1067.
22. Sizemore N, Leung S, Stark GR, (1999) Activation of Phosphatidylinositol 3-Kinase in Response to Interleukin-1 Leads to Phosphorylation and Activation of the NF-kappa B p65/RelA Subunit. Mol Cell Biol 19: 4798-4805.
23. Karin M, Greten FR, (2005) NF-[kappa]B: linking inflammation and immunity to cancer development and progression. Nat Rev Immunol 5: 749-759.
24. MacDonald NJ, Kuhl D, Maguire D, Näf D, Gallant P, et al. (1990) Different pathways mediate virus inducibility of the human IFN-[alpha]1 and IFN-[beta] genes. Cell 60: 767-779.
25. Matsusaka T, Fujikawa K, Nishio Y, Mukaida N, Matsushima K, et al. (1993) Transcription factors NF-IL6 and NF-kappa B synergistically activate transcription of the inflammatory cytokines, interleukin 6 and interleukin 8. Proceedings of the National Academy of Sciences of the United States of America 90: 10193-10197.
26. Sparmann A, Bar-Sagi D, (2004) Ras-induced interleukin-8 expression plays a critical role in tumor growth and angiogenesis. Cancer Cell 6: 447-458.
27. Grivennikov S, Karin E, Terzic J, Mucida D, Yu G-Y, et al. (2009) IL-6 and Stat3 Are Required for Survival of Intestinal Epithelial Cells and Development of Colitis-Associated Cancer. Cancer Cell 15: 103-113.
28. Jourdan M, Zhang XG, Portier M, Boiron JM, Bataille R, et al. (1991) IFN-alpha induces autocrine production of IL-6 in myeloma cell lines. The Journal of Immunology 147: 4402-4407.
29. Pestka S, Krause CD, Walter MR, (2004) Interferons, interferon-like cytokines, and their receptors. Immunological Reviews 202: 8-32.
30. Ludwig CU, Durie BGM, Salmon SE, Moon TE, (1983) Tumor growth stimulation in vitro by interferons. European Journal of Cancer and Clinical Oncology 19: 1625-1632.
31. da Silva AJ, Brickelmaier M, Majeau GR, Lukashin AV, Peyman J, et al. (2002) Comparison of gene expression patterns induced by treatment of human umbilical vein endothelial cells with IFN-alpha 2b vs. IFN-beta 1a: understanding the functional relationship between distinct type I interferons that act through a common receptor. J Interferon Cytokine Res 22: 173-188.
32. Yong VW, Chabot S, Stuve O, Williams G, (1998) Interferon beta in the treatment of multiple sclerosis: mechanisms of action. Neurology 51: 682-689.
33. Garcia-Lora A, Algarra I, Garrido F, (2003) MHC class I antigens, immune surveillance, and tumor immune escape. J Cell Physiol 195: 346-355.
34. Keydar I, Chen L, Karby S, Weiss FR, Delarea J, et al. (1979) Establishment and characterization of a cell line of human breast carcinoma origin. European Journal of Cancer (1965) 15: 659-670.
35. Rubinstein S, Familletti PC, Pestka S, (1981) Convenient assay for interferons. J Virol 37: 755-758.